P Labarga
Overview
Explore the profile of P Labarga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Montero J, Barreiro P, de Mendoza C, Labarga P, Soriano V
J Viral Hepat
. 2015 Sep;
23(1):47-52.
PMID: 26390144
Patients infected with HIV are at increased risk for cardiovascular disease despite successful antiretroviral therapy. Likewise, chronic hepatitis C virus (HCV) infection is associated with extrahepatic complications, including cardiovascular disease....
2.
Labarga P, Fernandez-Montero J, Barreiro P, Pinilla J, Vispo E, de Mendoza C, et al.
J Viral Hepat
. 2014 Apr;
21(7):475-9.
PMID: 24750394
There is scarce information about the impact of antiviral treatment on subsequent progression of liver fibrosis in HIV-infected patients with chronic hepatitis C who experience different outcomes following peginterferon-ribavirin therapy....
3.
Caruz A, Neukam K, Rivero-Juarez A, Herrero R, Real L, Camacho A, et al.
Genes Immun
. 2013 Nov;
15(1):16-24.
PMID: 24173146
Several data suggest that low-density lipoprotein receptor (LDLR) is a co-receptor for hepatitis C virus (HCV). Soluble LDLR can inhibit HCV infectivity; greater plasma low-density lipoprotein levels are associated with...
4.
Martin-Carbonero L, Tuma P, Vispo E, Medrano J, Labarga P, Gonzalez-Lahoz J, et al.
J Viral Hepat
. 2010 Sep;
18(8):542-8.
PMID: 20819149
The greatest benefit of hepatitis C virus (HCV) therapy is seen in cirrhotics attaining sustained virological response (SVR). However, concerns about toxicity and poorer responses often discourage treatment of cirrhotics....
5.
Medrano J, Resino S, Vispo E, Madejon A, Labarga P, Tuma P, et al.
J Viral Hepat
. 2010 May;
18(5):325-30.
PMID: 20456635
The efficacy of current hepatitis C therapy in HIV/HCV-coinfected patients is largely dependent on HCV genotype. The annual prevalence of HCV genotypes/subtypes and their influence on HCV clearance with antiviral...
6.
Blanco F, Barreiro P, Ryan P, Vispo E, Martin-Carbonero L, Tuma P, et al.
J Viral Hepat
. 2010 Jan;
18(1):11-6.
PMID: 20088890
Liver damage may result from multiple factors in HIV-infected patients. The availability of reliable noninvasive tools to measure liver fibrosis has permitted the screening of large patient populations. Cross-sectional study...
7.
Rallon N, Lopez M, Soriano V, Garcia-Samaniego J, Romero M, Labarga P, et al.
Clin Exp Immunol
. 2008 Dec;
155(1):35-43.
PMID: 19076827
CD4(+) regulatory T (T(reg)) cells have been involved in impaired immunity and persistence of viral infections. Herein, we report the level, phenotype and activation status of T(reg) cells in patients...
8.
Ryan P, Blanco F, Garcia-Gasco P, Garcia-Merchan J, Vispo E, Barreiro P, et al.
HIV Med
. 2008 Nov;
10(1):53-9.
PMID: 19018879
Objective: Multiple factors may lead to hepatic steatosis (HS) in HIV-positive patients. HS may result in severe liver damage on its own and/or by accelerating the progression of chronic viral...
9.
Castellares C, Barreiro P, Martin-Carbonero L, Labarga P, Vispo M, Casado R, et al.
J Viral Hepat
. 2008 Feb;
15(3):165-72.
PMID: 18233989
Liver disease is frequently seen in HIV+ patients as a result of coinfection with hepatitis B (HBV) or C (HCV) viruses, alcohol abuse and/or exposure to hepatotoxic drugs. The aim...
10.
de Ledinghen V, Barreiro P, Foucher J, Labarga P, Castera L, Vispo M, et al.
J Viral Hepat
. 2008 Jan;
15(6):427-33.
PMID: 18221303
The recent availability of non-invasive tools to measure liver fibrosis has allowed examination of its extent and determination of predictors in all patients with chronic hepatitis C virus (HCV) infection....